Is Clonazepam legal in New Zealand?

Also known as: klonopin

Legal status

Controlled, and named rather than inferred. Schedule 3 of the Misuse of Drugs Act 1975 names or describes clonazepam, a nitrobenzodiazepine used as an anticonvulsant, as a Class C controlled drug, and the entry reaches the relevant salts and preparations. New Zealand's list is closed for named substances, so a named entry settles the class without recourse to the section 2 controlled-drug-analogue limb that carries sixteen other rows in this table. Nimetazepam has its own row here and shares its class, and so do the other four benzodiazepines this table carries. This was read against the consolidation current at 20 September 2026; the 2026 Classification and Presumption of Supply Order was made but no commencement instrument was located by that horizon, so nothing it proposes is treated as law here.

Consequences if caught

Capital exposure: none. No capital sentence exists in New Zealand, and Class C is the lowest of the Act's three classes. For clonazepam the section 6 dealing maximum is 8 years, subject to the distinctions the Act draws around supply to adults, and the section 7 possession maximum is 3 months. English accounts that call the section 7 discretion decriminalisation are wrong, and the offence remains an offence. An anticonvulsant indication does not lower the section 6 position for a person who supplies tablets on to someone else.

If prescribed or medical

Not established for a traveller. This dossier carries no country-level rule for entering New Zealand with a prescribed medicine: it records that medicines status has to be checked alongside the analogue exclusions and the Psychoactive Substances Act 2013 route, and that a court-grade conclusion can turn on the medicine exclusions, but it states no declaration requirement, no permit, no quantity allowance and no carry limit at the border, and none was researched for this cell. What is established is the placement a traveller would be read against: clonazepam is a Class C controlled drug under Schedule 3, with sections 6 and 7 supplying the offences. Epilepsy treatment is a strong reason to be carrying a supply, and the placement should be read alongside a border rule that this dossier does not supply. Do not read that placement as a ruling on a lawfully prescribed and lawfully carried supply, which is a different question this cell does not answer. Settle the border question with the Ministry of Health, whose classification order implementation page this dossier cites, and with the New Zealand border authority, before travelling.

Documentation

Carry the Misuse of Drugs Act 1975 consolidation current at 20 September 2026, which is the official New Zealand Legislation text rather than a secondary summary. Read the Schedule 3 clonazepam entry beside section 7, and note that an anticonvulsant indication does not change the schedule. Carry the class and the ceiling as two separate readings, because Schedule 3 supplies the class for clonazepam while sections 6 and 7 supply the maximum. Carry the classification chain this finding was read against as well: the 2022 and 2025 Classification and Presumption of Supply Orders with their commencement orders, the 2024 pseudoephedrine amendment, and the 2026 Order, which was made but is not treated as law in this dossier because its own section 2 leaves commencement to the Governor-General and no commencement instrument was located by the horizon. Carry the date as well, 20 September 2026, because in New Zealand a classification order can move a substance between classes without a word of the Act changing.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.